Sherlock Biosciences: Raises $80M in Series B Funding

Sherlock Biosciences Raises $80M in Series B Funding

• Sherlock Biosciences, a Boston, MA-based biology diagnostics company, raised $80M in Series B funding.
• The company intends to use the funds to expand products and partnerships
• SherlockBiosciences is a company engineering biology to bring next-generation diagnostics to the point-of-need
• Powered by CRISPR and synthetic biology, Sherlock’s proprietary engineering biology tools form the foundation of its decentralized diagnostic platform for DNA and RNA detection
• In 2020 the company made history with the first FDA-authorized use of CRISPR technology